ChemoMetec AS (LTS:0DZ0) Other Net Income (Loss) : kr0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is ChemoMetec AS Other Net Income (Loss)?

ChemoMetec AS's Other Net Income (Loss) for the six months ended in Dec. 2024 was kr0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.0 Mil.

ChemoMetec AS's quarterly Other Net Income (Loss) increased from Dec. 2023 (kr-0.0 Mil) to Jun. 2024 (kr0.0 Mil) but then stayed the same from Jun. 2024 (kr0.0 Mil) to Dec. 2024 (kr0.0 Mil).

ChemoMetec AS's annual Other Net Income (Loss) declined from Jun. 2022 (kr0.0 Mil) to Jun. 2023 (kr-0.0 Mil) but then stayed the same from Jun. 2023 (kr-0.0 Mil) to Jun. 2024 (kr-0.0 Mil).

ChemoMetec AS Other Net Income (Loss) Historical Data

The historical data trend for ChemoMetec AS's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Other Net Income (Loss) Chart

ChemoMetec AS Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Net Income (Loss)

Get a 7-Day Free Trial

ChemoMetec AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

ChemoMetec AS Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.0 Mil.

ChemoMetec AS Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ChemoMetec AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (LTS:0DZ0) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

CHEMMc:UK CHEMM:Denmark CHY:Germany

Address

Gydevang 43, Allerod, DNK, 3450

Website

https://www.chemometec.com

ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines